Is Interferon Tissue Specific? — Effect of Human Leukocyte and Fibroblast Interferons on the Growth of Lymphoblastoid and Osteosarcoma Cell Lines

References

1. Adams A., Strander H., Cantell K. 1975; Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon. Journal of General Virology 28:207–217
   [Google Scholar]
2. Cantell K., Hirvonen S., Mogenson K. E., Pyhala L. 1974; Human leukocyte interferon: production purification, stability and animal experiments. In The Production and Use of Interferon for the Treatment and Prevention of Human Virus Infections. In Vitro monograph no 3:35–38
   [Google Scholar]
3. Edy V. G., Billiau A., De Somer P. 1976; Human fibroblast and leukocyte interferons show different response curves in assay of cell protection. Journal of General Virology 31:251–255
   [Google Scholar]
4. Fogh J., Trempe G. 1975; New human tumor cell lines. In Human Tumor Cells In vitro chapter 5 pp 115–159 Edited by Fogh J. New York and London: Plenum Press;
   [Google Scholar]
5. Giovanella B. C., Stehlin I. S., Williams L. J. Jun 1974; Heterotransplantation of human malignant tumours in ‘nude’ thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumor. Journal of the National Cancer Institute 59:921–930
   [Google Scholar]
6. Gresser L. 1976; Antitumor effects of interferon. In Cancer: A Comprehensive Treatise Edited by Becker F. (in the press.)
   [Google Scholar]
7. Havell E. A., Vilcek J. 1972; Production of high-titre interferon in cultures of human diploid cells. Antimicrobial Agents and Chemotherapy 2:476–484
   [Google Scholar]
8. Klein E., Klein G., Nadkarni J. S., Wigzell H., Clifford P. 1967; Surface IgM kappa specificity on a Burkitt lymphoma cell in vitro and in derived culture lines. Cancer Research 28:1300–1310
   [Google Scholar]
9. Knight E. 1976; Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon. Nature, London 262:302–303
   [Google Scholar]
10. Lockart R. Jun 1973; Criteria for acceptance of a viral inhibitor as interferon and a general description of the biological properties of known interferons. In Interferons and Interferon Inducers pp 11–27 Edited by Finter N. B. Amsterdam, London and New York: North Holland and American Elsevier;
    [Google Scholar]
11. Stewart W. E., Gresser I., Tovey M. G., Bandu M. T., Le Goff S. 1976; Identification of the cell multiplication inhibitory factors in interferon preparations as interferon. Nature, London 262:300–302
    [Google Scholar]
12. Strander H., Cantell K. 1966; Production of interferon by human leukocytes in vitro. Annales Medicime Experimentalis et Biologiae Fenniae 44:265–273
    [Google Scholar]
13. Strander H., Cantell K., Ingimarsson S., Jakobsson P. A., Nilsonne U., Soderberg G. 1976; Interferon treatment of osteogenic sarcoma - a clinical trial. Fogarty Int. Center Proceedings 28 Washington DC: U.S. Government Printing Office; (in the press)
    [Google Scholar]
14. Strander H., Einhorn S. 1977; Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. International Journal of Cancer (in the press)
    [Google Scholar]
15. Strander H., Mogenson K. E., Cantell K. 1975; Production of human lymphoblastoid interferon. Journal of Clinical Microbiology 1:116–117
    [Google Scholar]